Replies to post #81501 on NanoViricides Inc (NNVC)

[BeSeeingYou_No6]

Phase I trials, as a rule, use healthy volunteers.

Therefore, evidence of efficacy at that stage is unlikely.

[BIzzy]

That's an excellent point....in which case they will not need a partnership...just a calculator and a wheelbarrow to count and carry the $$$$$

[another_voice_2]

absolutely right. The particle is and has been used without any problems. The ligand along with the particle has been tried in 6,000 mice and rabbits, and ferrets(I think I remember). No tox but plenty of effects. Compared to the Gold standard (Tamiflu) they have NOT found a word to define 1,000 times better.
With the news about the new strains of viruses emerging this makes us that much more valuable. ATMOST, 60 days after first transfusion, stock will be UNTOUCHABLE. Thomas will have placed his hand in the wound.

[JG36]

They can easily get through phase I for Flucide without seeing efficacy results for the simplest of reasons: Phase I trials are done on healthy people. The participants in the study won't have the flu, nor will they be given a deliberate dose of the flu.

[Ubertino]

The curing of the flu will bring the larger pharma's to the table

I don't mind them at the table I just don't want them to buy the house.